Relay Therapeutics Stock (NASDAQ:RLAY), Quotes and News Summary

Q: What sector and industry does Relay Therapeutics (RLAY) operate in?

Relay Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Relay Therapeutics Stock (NASDAQ: RLAY) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 1.172M
Day Range	- - -
52 Wk Range	5.950 - 18.000
Market Cap	$809.375M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	29
Short Interest	10.96%
Days to Cover	8.73

Recent News

InMode, Daktronics, Domino's Pizza And Other Big Stocks Moving Higher On Wednesday

U.S. stocks traded higher, with the Dow Jones gaining around 250 points on Wednesday. Here are some big stocks recording gains in today’s session.

Lisa Levin

Why Relay Therapeutics Stock Is Trading Higher Today

Relay Therapeutics (NASDAQ: RLAY) shares are trading higher after Raymond James upgraded the stock from Outperform to Strong Buy and announced a $29 price target. Also, the stock is rebounding following yesterday's sell-off.

Sean Torres

Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Gainers Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) shares jumped 122% to $1.07 after the company announced the signing of a $60 million strategic investment with two institutional investors at $2.48 per share.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Dec 23

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Relay Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discover...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Relay Therapeutics (RLAY) stock?

You can purchase shares of Relay Therapeutics (NASDAQ: RLAY) through any online brokerage.

View our list of the best stock brokerages.

Who are Relay Therapeutics's (RLAY) competitors?

Other companies in Relay Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), ARS Pharmaceuticals (NASDAQ:SPRY), Cabaletta Bio (NASDAQ:CABA), 89bio (NASDAQ:ETNB) and Zentalis Pharma (NASDAQ:ZNTL).

What is the target price for Relay Therapeutics (RLAY) stock?

The latest price target for Relay Therapeutics (NASDAQ: RLAY) was reported by Stifel on Thursday, February 22, 2024. The analyst firm set a price target for 30.00 expecting RLAY to rise to within 12 months (a possible 386.22% upside). 10 analyst firms have reported ratings in the last year.

Current Stock Price for Relay Therapeutics (RLAY)?

The stock price for Relay Therapeutics (NASDAQ: RLAY) is $6.17 last updated April 18, 2024 at 4:27 PM EDT.

Does Relay Therapeutics (RLAY) pay a dividend?

There are no upcoming dividends for Relay Therapeutics.

When is Relay Therapeutics (NASDAQ:RLAY) reporting earnings?

Relay Therapeutics’s Q1 earnings are confirmed for Thursday, May 2, 2024.

Is Relay Therapeutics (RLAY) going to split?

There is no upcoming split for Relay Therapeutics.

What sector and industry does Relay Therapeutics (RLAY) operate in?

Relay Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-